Anti-Cryptosporidial Drug-Discovery Challenges and Existing Therapeutic Avenues: A “One-Health” Concern
Cryptosporidiosis is the leading cause of life-threatening diarrheal infection, especially in infants. Oocysts contaminate the environment, and also, being a zoonotic disease, cryptosporidiosis is a threat to One Health. Nitazoxanide is the only FDA-approved drug, effective only in immunocompetent a...
Main Authors: | Munwar Ali, Chang Xu, Shah Nawaz, Ahmed Ezzat Ahmed, Qazal Hina, Kun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/14/1/80 |
Similar Items
-
Chemical profiling of Verbena officinalis and assessment of its anti-cryptosporidial activity in experimentally infected immunocompromised mice
by: Eman S. El-Wakil, et al.
Published: (2022-07-01) -
Pulmonary Cryptosporidiosis in HIV Infected Patients at Imam Khomeini Complex Hospital in Tehran, Iran: A Case Series
by: Saghi Rashidifar, et al.
Published: (2025-02-01) -
Herbal-based compounds: A review on treatments of cryptosporidiosis
by: Fatemeh Namazi, et al.
Published: (2024-04-01) -
Food and Waterborne Cryptosporidiosis from a One Health Perspective: A Comprehensive Review
by: Munwar Ali, et al.
Published: (2024-11-01) -
Plants Used in Ethnoveterinary Medicine in Cows. A Review
by: Cristina EL MAHDY, et al.
Published: (2019-11-01)